These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Predictive value of estrogen receptors evaluated by quantitative immunohistochemical analysis in breast cancer. Esteban JM; Ahn C; Battifora H; Felder B Am J Clin Pathol; 1994 Oct; 102(4 Suppl 1):S9-12. PubMed ID: 7942615 [TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical detection of hormone receptors in breast carcinomas (ER-ICA, PgR-ICA): prognostic usefulness and comparison with the biochemical radioactive-ligand-binding assay (DCC). Beck T; Weikel W; Brumm C; Wilkens C; Pollow K; Knapstein PG Gynecol Oncol; 1994 May; 53(2):220-7. PubMed ID: 8188083 [TBL] [Abstract][Full Text] [Related]
4. Simultaneous immunohistochemical and biochemical hormone receptor assessment in breast cancer provides complementary prognostic information. Biesterfeld S; Schröder W; Steinhagen G; Koch R; Veuskens U; Schmitz FJ; Handt S; Böcking A Anticancer Res; 1997; 17(6D):4723-9. PubMed ID: 9494596 [TBL] [Abstract][Full Text] [Related]
5. Estrogen and progesterone receptors in breast cancer: comparison between enzyme immunoassay and computer-assisted image analysis of immunocytochemical assay. Cavaliere A; Bucciarelli E; Sidoni A; Bianchi G; Pietropaoli N; Ludovini V; Vitali R Cytometry; 1996 Sep; 26(3):204-8. PubMed ID: 8889392 [TBL] [Abstract][Full Text] [Related]
6. Estimation of PR and ER by immunocytochemistry in breast cancer. Comparison with radioligand binding methods. Seymour L; Meyer K; Esser J; MacPhail AP; Behr A; Bezwoda WR Am J Clin Pathol; 1990 Oct; 94(4 Suppl 1):S35-40. PubMed ID: 1699410 [TBL] [Abstract][Full Text] [Related]
7. Interobserver reproducibility of immunocytochemical estrogen- and progesterone receptor status assessment in breast cancer. Biesterfeld S; Veuskens U; Schmitz FJ; Amo-Takyi B; Böcking A Anticancer Res; 1996; 16(5A):2497-500. PubMed ID: 8917341 [TBL] [Abstract][Full Text] [Related]
8. Quality assurance for detection of estrogen and progesterone receptors by immunohistochemistry in Austrian pathology laboratories. Regitnig P; Reiner A; Dinges HP; Höfler G; Müller-Holzner E; Lax SF; Obrist P; Rudas M; Quehenberger F Virchows Arch; 2002 Oct; 441(4):328-34. PubMed ID: 12404057 [TBL] [Abstract][Full Text] [Related]
9. Quantitative assessment of oestrogen and progesterone receptors on fine-needle aspirates and cryostat sections of breast carcinomas: how does this compare with biochemical assays? Muchiri LW East Afr Med J; 1993 May; 70(5):280-3. PubMed ID: 8306903 [TBL] [Abstract][Full Text] [Related]
10. [Clinical follow-up studies on the prognostic significance of immunohistochemical estrogen receptor determination of breast cancer]. Beck T; Finger C; Weikel W; Mitze M; Kreienberg R Geburtshilfe Frauenheilkd; 1990 Dec; 50(12):935-40. PubMed ID: 2086335 [TBL] [Abstract][Full Text] [Related]
11. Re-evaluating adjuvant breast cancer trials: assessing hormone receptor status by immunohistochemical versus extraction assays. Regan MM; Viale G; Mastropasqua MG; Maiorano E; Golouh R; Carbone A; Brown B; Suurküla M; Langman G; Mazzucchelli L; Braye S; Grigolato P; Gelber RD; Castiglione-Gertsch M; Price KN; Coates AS; Goldhirsch A; Gusterson B; J Natl Cancer Inst; 2006 Nov; 98(21):1571-81. PubMed ID: 17077359 [TBL] [Abstract][Full Text] [Related]
12. Quantitative immunohistochemistry using the CAS 200/486 image analysis system in invasive breast carcinoma: a reproducibility study. Makkink-Nombrado SV; Baak JP; Schuurmans L; Theeuwes JW; van der Aa T Anal Cell Pathol; 1995 Apr; 8(3):227-45. PubMed ID: 7547496 [TBL] [Abstract][Full Text] [Related]
13. Immunohistochemical estrogen receptor assay: quantitation by image analysis. el-Badawy N; Cohen C; DeRose PB; Sgoutas D Mod Pathol; 1991 May; 4(3):305-9. PubMed ID: 2068055 [TBL] [Abstract][Full Text] [Related]
14. Rapid and prognostically valid quantification of immunohistochemical reactions by immunohistometry of the most positive tumour focus. A prospective follow-up study on breast cancer using antibodies against MIB-1, PCNA, ER, and PR. Biesterfeld S; Klüppel D; Koch R; Schneider S; Steinhagen G; Mihalcea AM; Schröder W J Pathol; 1998 May; 185(1):25-31. PubMed ID: 9713356 [TBL] [Abstract][Full Text] [Related]
15. [Breast cancer: prognostic value of flow cytometry and hormone receptors. Apropos of a Lebanese series of patients]. Aftimos G; Trak-Smayra V; Moacdieh-Rehayel L J Med Liban; 2000; 48(1):8-17. PubMed ID: 10881437 [TBL] [Abstract][Full Text] [Related]
16. Immunocytochemical assay of estrogen and progesterone receptors in fine needle aspirates from breast cancer patients. Nizzoli R; Bozzetti C; Savoldi L; Manotti L; Naldi N; Camisa R; Soresi AP; Guazzi A; Cocconi G Acta Cytol; 1994; 38(6):933-8. PubMed ID: 7992582 [TBL] [Abstract][Full Text] [Related]
17. Multiparametric analysis (SAMBA 200) of the progesterone receptor immunocytochemical assay in nonmalignant and malignant breast disorders. Charpin C; Jacquemier J; Andrac L; Vacheret H; Habib MC; Devictor B; Lavaut MN; Toga M Am J Pathol; 1988 Aug; 132(2):199-211. PubMed ID: 2456699 [TBL] [Abstract][Full Text] [Related]
18. Biologic significance of quantitative estrogen receptor immunohistochemical assay by image analysis in breast cancer. Esteban JM; Ahn C; Mehta P; Battifora H Am J Clin Pathol; 1994 Aug; 102(2):158-62. PubMed ID: 8042582 [TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical detection of estrogen and progesterone receptors performed with an antigen-retrieval technique on methacarn-fixed paraffin-embedded breast cancer tissues. Oyaizu T; Arita S; Hatano T; Tsubura A J Surg Res; 1996 Jan; 60(1):69-73. PubMed ID: 8592434 [TBL] [Abstract][Full Text] [Related]
20. Quantitation and morphometric analysis of tumors by image analysis. Aziz DC; Barathur RB J Cell Biochem Suppl; 1994; 19():120-5. PubMed ID: 7823583 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]